I cannot understand why the full 2a results, at least, have not been released. It has been over 90 days since any dosing, and all data should be complete. There were only 4 participants, so the processing could be done in about 30 minutes. The 2b study may still need 90-day follow-up data to be completed. At least there has to be a 3-monthly progress report review and statement by the end of the month.
Ann: ISLA-101 shows anti-dengue activity in Phase 2a readout, page-184
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.010(6.06%) |
Mkt cap ! $36.59M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.0¢ | 15.0¢ | $139.0K | 882.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13834 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 2104 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| ILA (ASX) Chart |